Amphetamines: a current epidemic
In addition, two participants (4% of randomised participants) in the aripiprazole arm discontinued the study due to adverse events. Aripiprazole was assessed in two studies on its own 28, 62, and once in a study that also had a second active agent arm—methylphenidate . This study was not placebo controlled, control participants were provided with…




